Gojo, Javelle B.

HRN: 28-18-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2025
AMPICILLIN 250MG (VIAL)
11/30/2025
07/12/2025
IV
140mg
Q12h
Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Disseminated Systemic InfectionUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines